The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

50 articles for J Ren


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
A novel class ofa-glucosidase and HMG-CoA reductase inhibitors from Ganoderma leucocontextum and the anti-diabetic properties of ganomycin I in KK-AEBI
Chinese Academy of Sciences
Cembranoids from the Gum Resin of Boswellia carterii as Potential Antiulcerative Colitis Agents.EBI
Peking Union Medical College
Novel 2H-chromen-2-one derivatives of resveratrol: Design, synthesis, modeling and use as human monoamine oxidase inhibitors.EBI
Hefei University of Technology
Synthesis and biological evaluation of 3-phenyl-3-aryl carboxamido propanoic acid derivatives as small molecule inhibitors of retinoic acid 4-hydroxylase (CYP26A1).EBI
Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)
Discovery of potent N-(isoxazol-5-yl)amides as HSP90 inhibitors.EBI
Chinese Academy of Sciences
Identification of a new series of potent diphenol HSP90 inhibitors by fragment merging and structure-based optimization.EBI
Chinese Academy of Sciences
Thermodynamic and structural characterization of halogen bonding in protein-ligand interactions: a case study of PDE5 and its inhibitors.EBI
Chinese Academy of Sciences (Cas)
Synthesis, biological evaluation, and molecular modeling of glycyrrhizin derivatives as potent high-mobility group box-1 inhibitors with anti-heart-failure activity in vivo.EBI
Peking Union Medical College
Design, synthesis, and pharmacological evaluation of monocyclic pyrimidinones as novel inhibitors of PDE5.EBI
Chinese Academy of Sciences
Synthesis and anti-liver fibrosis activity of imidazole and thiazole compounds containing amino acids.EBI
Yanbian University
Discovery of novel SOS1 inhibitors using machine learning.EBI
University of Nottingham Ningbo China
Discovery of a Bromodomain and Extra Terminal Domain (BET) Inhibitor with the Selectivity for the Second Bromodomain (BD2) and the Capacity for the Treatment of Inflammatory Diseases.EBI
China Pharmaceutical University
Design and synthesis of boron-containing ALK inhibitor with favorable in vivo efficacy.EBI
Nanjing University
Discovery of a Potent FLT3 Inhibitor (LT-850-166) with the Capacity of Overcoming a Variety of FLT3 Mutations.EBI
China Pharmaceutical University
Discovery and biological evaluation of tanshinone derivatives as potent dual inhibitors of indoleamine 2, 3-dioxygenase 1 and tryptophan 2, 3-dioxygenase.EBI
Kunming Institute of Botany
Synthesis and in vitro biological evaluation of 3-ethyl-1,5-naphthyridin-2(1H)-one derivatives as potent PARP-1 selective inhibitors and PARP-1 DNA trappers.EBI
China Pharmaceutical University
Selective inhibition of matrix metalloproteinase isozymes and in vivo protection against emphysema by substituted gamma-keto carboxylic acids.EBI
Chinese Academy of Sciences
Design and synthesis of N-[(4-methoxyphenoxy)carbonyl]-N-[[4-[2-(5- methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine [Muraglitazar/BMS-298585], a novel peroxisome proliferator-activated receptor alpha/gamma dual agonist with efficacious glucose and lipid-lowering activities.EBI
Bristol-Myers Squibb Pharmaceutical Research Institute
Identification and structural analysis of a selective tropomyosin receptor kinase C (TRKC) inhibitor.EBI
China Pharmaceutical University
Discovery of selective CDK9 degraders with enhancing antiproliferative activity through PROTAC conversion.EBI
China Pharmaceutical University
Discovery of imidazopyrrolopyridines derivatives as novel and selective inhibitors of JAK2.EBI
China Pharmaceutical University
Design and synthesis of boron-containing diphenylpyrimidines as potent BTK and JAK3 dual inhibitors.EBI
Chia Tai Tianqing Pharmaceutical Group
Antiepileptic Drug Carbamazepine Binds to a Novel Pocket on the Wnt Receptor Frizzled-8.EBI
University of Oxford
Design, synthesis and biological evaluation of 3,5-dimethylisoxazole and pyridone derivatives as BRD4 inhibitors.EBI
Sichuan University
Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via high-throughput screening and molecular modeling.EBI
University of Illinois At Chicago
Design, synthesis and biological evaluation of hypolipidemic compounds based on BRD4 inhibitor RVX-208.EBI
Southeast University
Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors.EBI
Oxford University
Exploration of the 5-bromopyrimidin-4(3H)-ones as potent inhibitors of PDE5.EBI
Chinese Academy of Sciences
Discovery of small molecule inhibitors of adenovirus by disrupting E3-19K/HLA-A2 interactions.EBI
University of Illinois At Chicago
Identification of highly potent N-acylethanolamine acid amidase (NAAA) inhibitors: Optimization of the terminal phenyl moiety of oxazolidone derivatives.EBI
Chinese Academy of Sciences
Bioactive Azaphilone Derivatives from the Fungus Talaromyces aculeatus.EBI
Hebei University
Structures of Ebola Virus Glycoprotein Complexes with Tricyclic Antidepressant and Antipsychotic Drugs.EBI
University of Oxford
A novel series of enoyl reductase inhibitors targeting the ESKAPE pathogens, Staphylococcus aureus and Acinetobacter baumannii.EBI
Novalex Therapeutics
Target Identification and Mode of Action of Four Chemically Divergent Drugs against Ebolavirus Infection.EBI
University of Oxford
Design and optimization of purine derivatives as in vivo active PDE10A inhibitors.EBI
Nanchang University
JAK kinase inhibitor, preparation method for same, and applications thereof in field of medicineBDB
Shanghai Synergy Pharmaceutical Sciences Co.
CRYSTALLINE FORMS OF AN INHIBITOR OF THE MENIN/MLL INTERACTIONBDB
Janssen Pharmaceutica
Aminonorbornane derivative and manufacture method therefor and use thereofBDB
Transthera Sciences (Nanjing)
HETEROARYL DERIVATIVE AND USES THEREOFBDB
Iucf-Hyu
Naphthyridinone derivatives for the treatment of a disease or disorderBDB
Novartis
IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AS IRAK4 INHIBITORS AND THEIR USE IN THE TREATMENT OF DISEASEBDB
Biogen Ma
MACROCYCLIC HETEROCYCLES AND USES THEREOFBDB
Kumquat Biosciences
ANTAGONIST COMPOUNDSBDB
AdoRx Therapeutics
Prodrugs of pyridone amides useful as modulators of sodium channelsBDB
Vertex Pharmaceuticals
Synergistic combination of immunologic inhibitors for the treatment of cancerBDB
The University of Chicago
Ethynyl derivativesBDB
Hoffmann-La Roche
Arylaminoalcohol-substituted 2,3-dihydroimidazo[1,2-C]quinolinesBDB
Bayer Intellectual Property